PharmiWeb.com - Global Pharma News & Resources

Press Releases

Date Title Company
19-Aug-2024 Ombudsman warns of surge in maternity investigations England’s Health Ombudsman
19-Aug-2024 UK must get ready for new cell and gene therapies, says ABPI Advanced Therapy Medicinal Products (ATMPs),
19-Aug-2024 Supply chain resilience in pharma: Delivering consistency amidst global events Bachem
19-Aug-2024 Ainos Unveils AI Nose Breakthrough that Revolutionizes Smart Manufacturing Factory Automation and Manufacturing Safety AccessWire
19-Aug-2024 Positive Results from Lexaria's Molecular Characterization Study AccessWire
19-Aug-2024 Sheila Savageau Joins the IntoValue Board of Directors AccessWire
19-Aug-2024 Original-Research: Formycon AG (von First Berlin Equity Research GmbH) Formycon AG
19-Aug-2024 Sunshine Biopharma Reports 2024 Second Quarter Results: Second QTR Revenues up 67%, YTD Revenues up 61% AccessWire
19-Aug-2024 MIRA Pharmaceuticals Showcases Significant Progress and Announces Final Phase of Regulatory Work as It Prepares for IND Submission by Year-End AccessWire
19-Aug-2024 MIRA Pharmaceuticals Showcases Significant Progress and Announces Final Phase of Regulatory Work as It Prepares for IND Submission by Year-End Newswire
19-Aug-2024 MindBio Announces Sustained Antidepressant Response 3-Months Post Treatment in Microdosing Depression Clinical Trials AccessWire
19-Aug-2024 Tanvex BioPharma USA, Inc. Achieves Dual U.S. Regulatory Milestones: FDA Approves Nypozi™ and FDA Accepts Biosimilar Biologics License Application for TX-05 Newswire
19-Aug-2024 uBriGene Biosciences Congratulates Strategic Partner InnoVec Biotherapeutics on FDA Clearance of IND for IVB103, an AAV-Based Gene Therapy Newswire
19-Aug-2024 uBriGene Biosciences Congratulates Strategic Partner InnoVec Biotherapeutics on FDA Clearance of IND for IVB103, an AAV-Based Gene Therapy AccessWire
19-Aug-2024 Tanvex BioPharma USA, Inc. Achieves Dual U.S. Regulatory Milestones: FDA Approves Nypozi(TM) and FDA Accepts Biosimilar Biologics License Application for TX-05 AccessWire
19-Aug-2024 Simulab Corporation Releases New AirwayBaby(TM) Infant Airway Management Trainer AccessWire
19-Aug-2024 NanoViricides Continues Its March Towards a Phase II Clinical Trial of NV-387 -
A Potentially Revolutionary First Line Antiviral Therapy for RSV, COVID, and Other Viral Infections AccessWire
19-Aug-2024 Syngene secures silver rating in EcoVadis sustainability index, ranking in top 15% of assessed companies Syngene
19-Aug-2024 QuantaMatrix unveils world’s fastest antimicrobial testing technology backed by research paper in Nature Andrew Lloyd Associates
17-Aug-2024 Life Rx Celebrates Helping 35,000 Patients Achieve Wellness Success AccessWire